Rx Only Topical Suspension in a vehicle containing Green Tea and Aloe DESCRIPTION Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent .
Chemically sodium sulfacetamide is N - [ ( 4 - aminophenyl ) sulfonyl ] - acetamide , monosodium salt , monohydrate .
The structural formula is : [ MULTIMEDIA ] Each mL of SulfaCleanse ® 8 / 4 ( sodium sulfacetamide 8 % & sulfur 4 % ) contains 80 mg of sodium sulfacetamide and 40 mg of sulfur in a formulation consisting of : aloe barbadensis gel , butylated hydroxytoluene , cetyl alcohol , disodium oleamido MEA sulfosuccinate , edetate disodium , glyceryl stearate , green tea extract , magnesium aluminum silicate , methylparaben , PEG - 100 stearate , petrolatum , propylparaben , purified water , sodium cocoyl isethionate , sodium methyl cocoyl taurate , sodium thiosulfate , stearyl alcohol , xanthan gum .
[ MULTIMEDIA ] CLINICAL PHARMACOLOGY The most widely accepted mechanism of action of sulfonamides is the Woods - Fildes theory , which is based on the fact that sulfonamides act as competitive antagonists to paraaminobenzoic acid ( PABA ) , an essential component for bacterial growth .
While absorption through intact skin has not been determined , sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine , largely unchanged .
The biological half - life has variously been reported as 7 to 12 . 8 hours .
The exact mode of action of sulfur in the treatment of acne is unknown , but it has been reported that it inhibits the growth of Propionibacterium acnes and the formation of free fatty acids .
INDICATIONS SulfaCleanse ® 8 / 4 ( sodium sulfacetamide 8 % & sulfur 4 % ) is indicated for the topical control of acne vulgaris , acne rosacea and seborrheic dermatitis .
CONTRAINDICATIONS SulfaCleanse ® 8 / 4 ( sodium sulfacetamide 8 % & sulfur 4 % ) is contraindicated for use by patients having known hypersensitivity to sulfonamides , sulfur or any other component of this preparation .
SulfaCleanse ® 8 / 4 ( sodium sulfacetamide 8 % & sulfur 4 % ) is not to be used by patients with kidney disease .
WARNINGS Although rare , sensitivity to sodium sulfacetamide may occur .
Therefore , caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides .
Systemic toxic reactions such as agranulocytosis , acute hemolytic anemia , purpura hemorrhagica , drug fever , jaundice , and contact dermatitis indicate hypersensitivity to sulfonamides .
Particular caution should be employed if areas of denuded or abraded skin are involved .
FOR EXTERNAL USE ONLY .
Keep away from eyes .
Keep out of reach of children .
Keep container tightly closed .
PRECAUTIONS General If irritation develops , use of the product should be discontinued and appropriate therapy instituted .
Patients should be carefully observed for possible local irritation or sensitization during long - term therapy .
The object of this therapy is to achieve desquamation without irritation , but sodium sulfacetamide and sulfur can cause reddening and scaling of the epidermis .
These side effects are not unusual in the treatment of acne vulgaris , but patients should be cautioned about the possibility .
Information for Patients Avoid contact with eyes , eyelids , lips and mucous membranes .
If accidental contact occurs , rinse with water .
If excessive irritation develops , discontinue use and consult your physician .
Carcinogenesis , Mutagenesis and Impairment of Fertility Long - term studies in animals have not been performed to evaluate carcinogenic potential .
PREGNANCY Category C Animal reproduction studies have not been conducted with SulfaCleanse ® 8 / 4 ( sodium sulfacetamide 8 % & sulfur 4 % ) .
It is also not known whether SulfaCleanse ® 8 / 4 ( sodium sulfacetamide 8 % & sulfur 4 % ) can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity .
SulfaCleanse ® 8 / 4 ( sodium sulfacetamide 8 % & sulfur 4 % ) should be given to a pregnant woman only if clearly needed .
NURSING MOTHERS It is not known whether sodium sulfacetamide is excreted in the human milk following topical use of SulfaCleanse ® 8 / 4 ( sodium sulfacetamide 8 % & sulfur 4 % ) .
However , small amounts of orally administered sulfonamides have been reported to be eliminated in human milk .
In view of this and because many drugs are excreted in human milk , caution should be exercised when SulfaCleanse ® 8 / 4 ( sodium sulfacetamide 8 % & sulfur 4 % ) is administered to a nursing woman .
PEDIATRIC USE Safety and effectiveness in children under the age of 12 has not been established .
ADVERSE REACTIONS Although rare , sodium sulfacetamide may cause local irritation .
DOSAGE AND ADMINISTRATION Apply SulfaCleanse ® 8 / 4 ( sodium sulfacetamide 8 % & sulfur 4 % ) once or twice daily to affected areas , or as directed by your physician .
Wet skin and liberally apply to areas to be cleansed .
Massage gently into skin for 10 - 20 seconds , working into a full lather , rinse thoroughly and pat dry .
If drying occurs , it may be controlled by rinsing off SulfaCleanse ® 8 / 4 ( sodium sulfacetamide 8 % & sulfur 4 % ) sooner or using less often .
HOW SUPPLIED SulfaCleanse ® 8 / 4 ( sodium sulfacetamide 8 % & sulfur 4 % ) is available in a 16 fl .
oz .
( 473 mL ) bottle , NDC 42546 - 175 - 16 .
Store at 20 ° C to 25 ° C ( 68 ° F to 77 ° F ) , excursions permitted between 15 ° C and 30 ° C ( between 59 ° F and 86 ° F ) .
Brief exposure to temperatures up to 40 ° C ( 104 ° F ) may be tolerated provided the mean kinetic temperature does not exceed 25 ° C ( 77 ° F ) ; however , such exposure should be minimized .
Protect from freezing .
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN .
Manufactured for : PruGen Pharmaceuticals 18899 N Thompson Peak Pkwy Scottsdale , AZ 85255 Rev . 4 . 0 PRINCIPAL DISPLAY PANEL - 473 ml Bottle Box NDC 42546 - 175 - 16 SulfaCleanse ® 8 / 4 ( sodium sulfacetamide 8 % & sulfur 4 % ) Topical Suspension in a vehicle containing Green Tea and Aloe Rx only 16 fl oz ( 473 ml ) PRUGEN ® PHARMACEUTICALS [ MULTIMEDIA ] [ MULTIMEDIA ]
